Mechanism(s) of alteration of micro rna expressions in huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease

NeuroMolecular Medicine

Volumn 14, Issue 4, 2012, Pages 221-243

  Sinha, Mithun ^a   Mukhopadhyay, Saikat ^a   Bhattacharyya, Nitai P ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

Author keywords

Biological pathways; Huntington's disease; MicroRNAs; Transcription regulation

Indexed keywords

MICRORNA; MICRORNA 106A; MICRORNA 107; MICRORNA 124; MICRORNA 127; MICRORNA 132; MICRORNA 136; MICRORNA 144; MICRORNA 17; MICRORNA 18A; MICRORNA 18B; MICRORNA 19A; MICRORNA 19B; MICRORNA 20A; MICRORNA 212; MICRORNA 337; MICRORNA 363; MICRORNA 431; MICRORNA 433; MICRORNA 451; MICRORNA 665; MICRORNA 92A; MICRORNA 95; PROTEIN P53; PROTEIN REST; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

APOPTOSIS; CARBOHYDRATE METABOLISM; CELL CYCLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MATURATION; CHOLESTEROL METABOLISM; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MODEL; DOWN REGULATION; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GENE LOCATION; GENE TARGETING; GLUCOSE METABOLISM; HUMAN; HUNTINGTON CHOREA; INTRON; LIPID METABOLISM; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVIEW; RNA ANALYSIS; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; APOPTOSIS; BRAIN; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HUNTINGTON DISEASE; INTRONS; MALE; METABOLISM; MICRORNAS; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84870483497     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-012-8183-0     Document Type: Review

References (71)

1. Bae, B. I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., et al. (2005). p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron, 47, 29-41. doi: 10.1016/j.neuron.2005.06.005.
2. Baskerville, S., & Bartel, D. P. (2005). Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA, 11, 241-247. doi:10.1261/rna.7240905.
3. Bazzoni, F., Rossato, M., Fabbri, M., Gaudiosi, D., MiRolo, M., Mori, L., et al. (2009). Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proceedings of the National academy of Sciences of the United States of America, 106, 5282-5287. doi:10.1073/pnas. 0810909106.
4. Benn, C. L., Sun, T., Sadri-Vakili, G., McFarland, K. N., DiRocco, D. P., Yohrling, G. J., et al. (2008). Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. The Journal of Neuroscience, 28, 10720-10733. doi:10.1523/NEUROSCI.2126- 08.2008.
5. Block, R. C., Dorsey, E. R., Beck, C. A., Brenna, J. T., & Shoulson, I. (2010). Altered cholesterol and fatty acid metabolism in Huntington disease. Journal of Clinical Lipidology, 4, 17-23. doi:10.1016/j.jacl.2009.11.003.
6. Blockx, I., De Groof, G., Verhoye, M., Van Audekerke, J., Raber, K., Poot, D., et al. (2011). Microstructural changes observed with DKI in a transgenic Huntington rat model: Evidence for abnormal neurodevelopment. Neuroimage, Aug30, (Epub ahead of print). doi:10.1016/j.neuroimage.2011.08.062.
7. Buckley, N. J., Johnson, R., Zuccato, C., Bithell, A., & Cattaneo, E. (2010). The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease. Neurobiology of Disease, 39, 28-39. doi:10.1016/j.nbd. 2010.02.003.
8. Burton, A. (2005). Possible role for p53 in Huntington's disease. The Lancet Neurology, 9, 528-529. doi:10.1016/S1474-4422(05) 70157-5.
9. Caia, Y., Yu, X., Hu, S., & Yu, J. (2009). A brief review on the mechanisms of miRNA regulation. Genomics, Proteomics & Bioinformatics, 7, 147-154. doi:10.1016/S1672-0229(08)60044-3.
10. Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M., & Pascual-Montano, A. (2007). GENECODIS: A web-based tool for finding significant concurrent annotations in gene lists. Genome Biology, 8, R3. doi:10.1186/gb-2007-8-1-r3.
11. Cha, J. H. (2007). Transcriptional signatures in Huntington's disease. Progress in Neurobiology, 83, 228-248. doi:10.1016/j.pneuro bio.2007.03.004.
12. Datta, M., & Bhattacharyya, N. P. (2011). Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI). Journal of Biological Chemistry, 286, 33759-33769. Epub 2011 Aug 6.doi:10.1074/jbc.M111.265173.
13. Denny, C. A., Desplats, P. A., Thomas, E. A., & Seyfried, T. N. (2010). Cerebellar lipid differences between R6/1 transgenic mice and humans with Huntington's disease. Journal of Neurochemistry, 115, 748-758. doi:10.1111/j.1471-4159.2010.06964.x.
14. Djuranovic, S., Nahvi, A., & Green, R. (2011). A parsimonious model for gene regulation by miRNAs. Science, 331, 550-553. doi: 10.1126/science. 1191138.
15. Dragatsis, I., Efstratiadis, A., & Zeitlin, S. (1998). Mouse mutant embryos lacking huntingtin are rescued from lethality by wildtype extraembryonic tissues. Development, 125, 1529-1539.
16. Fedele, V., Roybon, L., Nordstrom, U., Li, J. Y., & Brundin, P. (2011). Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1. Neuroscience, 173, 76-81. doi:10.1016/j.neuroscience. 2010.08.022.
17. Friedlander, R. M. (2003). Apoptosis and caspases in neurodegenerative diseases. The New England Journal of Medicine, 348, 1365-1375.
18. Friedman, R. C., Farh, K. K., Burge, C. B., & Bartel, D. P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Research, 19, 92-105. doi:10.1101/gr.082701.108.
19. Gaughwin, P. M., Ciesla, M., Lahiri, N., Tabrizi, S. J., Brundin, P., & Bjorkqvist, M. (2011). Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Human Molecular Genetics, 20, 2225-2237. doi:10.1093/hmg/ddr111.
20. Ghose, J., Sinha, M., Das, E., Jana, N. R., & Bhattacharyya, N. P. (2011). Regulation of miR-146a by RelA/NFkB and p53 in STHdhQ111/HdhQ111 Cells, a cell model of Huntington's disease. PLoS ONE, 6. e23837. doi:10.1371/journal. pone.002 3837.
21. Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2011). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature, 466, 835-840. doi:10.1038/nature09267.
22. Hébert, S. S., & Strooper, B. D. (2007). miRNAs in neurodegeneration. Science, 317, 1179-1180. doi:10.1126/science.1148530.
23. Hermeking, H. (2007). p53 enters the microRNA world. Cancer Cell, 12, 414-418. doi:10.1016/j.ccr.2007.10.028.
24. Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., et al. (2006). Regional and cellular gene expression changes in human Huntington's disease brain. Human Molecular Genetics, 15, 965-977. doi:10.1093/hmg/ddl013.
25. Hsu, S. D., Lin, F. M., Wu, W. Y., Liang, C., Huang, W. C., Chan, W. L. et al. (2011). miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Research, 39, Database issue, D163-D169. doi:10.1093/nar/gkq 1107.
26. Humbert, S. (2010). Is Huntington disease a developmental disorder EMBO Reports, 11, 899. doi:10.1038/embor.2010.182.
27. Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C. W., Saiki, S., Rose, C., et al. (2008). Huntington's disease: From pathology and genetics to potential therapies. Biochemical Journal, 412, 191-209. doi:10.1042/BJ20071619.
28. Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., et al. (2009). miR2Disease: A manually curated database for microRNA deregulation in human disease. Nucleic Acids Research, 37, D98-D104. doi:10.1093/nar/gkn714.
29. Johnson, R., & Buckley, N. J. (2009). Gene dysregulation in Huntington's disease: REST, microRNAs and beyond. Neuro- Molecular Medicine, 11, 183-199. doi:10.1007/s12017-009- 8063-4.
30. Johnson, R., Zuccato, C., Belyaev, N. D., Guest, D. J., Cattaneo, E., & Buckley, N. J. (2008). A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiology of Disease, 29, 438-445. doi:10.1016/j.nbd. 2007.11.001.
31. Josefsen, K., Nielsen, S. M., Campos, A., Seifert, T., Hasholt, L., Nielsen, J. E., et al. (2010). Reduced gluconeogenesis and lactate clearance in Huntington's disease. Neurobiology of Disease, 40, 656-662. doi:10.1016/j.nbd. 2010.08.009.
32. Lee, S. T., Chu, K., Im, W. S., Yoon, H. J., Im, J. Y., Park, J. E., et al. (2010). Altered microRNA regulation in Huntington's disease models. Experimental Neurology, 227, 172-179. doi:10.1016/j. expneurol.2010.10.012.
33. Lee, M. T. N., The, C., Shyh-Chang, N., Xie, H., Zhou, B., Korzh, V., et al. (2009). MicroRNA-125b is a novel negative regulator of p53. Genes & Development, 23, 862-876. doi:10.1101/gad. 1767609.
34. Leoni, V., Mariotti, C., Nanetti, L., Salvatore, E., Squitieri, F., Bentivoglio, A. R., et al. (2011). Whole body cholesterol metabolism is impaired in Huntington's disease. Neuroscience Letters, 494, 245-249. doi:10.1016/j.neulet.2011.03.025.
35. Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20. doi: 10.1016/j.cell.2004.12.035.
36. Liang, Y., Ridzon, D., Wong, L., & Chen, C. (2007). Characterization of microRNA expression profiles in normal human tissues. BMC Genomics, 12, 166. doi:10.1186/1471-2164-8-166.
37. Liu, J. (2008). Control of protein synthesis and mRNA degradation by microRNAs. Current Opinion in Cell Biology, 20, 214-221. doi: 10.1016/j.ceb.2008.01.006.
38. Martí, E., Pantano, L., Banez-Coronel, M., Llorens, F., Minones- Moyano, E., Porta, S., et al. (2010). A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Research, 38, 7219-7235. doi:10.1093/nar/gkq575.
39. Martin, W. R., Clark, C., Ammann, W., Stoessl, A. J., Shtybel, W., & Hayden, M. R. (1992). Cortical glucose metabolism in Huntington's disease. Neurology, 42, 223-229.
40. Marullo, M., Valenza, M., Mariotti, C., Di Donato, S., Cattaneo, E., & Zuccato, C. (2010). Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease. Brain Pathology, 20, 96-105. doi: 10.1111/j.1750-3639.2008.00249.x.
41. Mazurová, Y., Rudolf, E., Látr, I., & Osterreicher, J. (2006). Proliferation and differentiation of adult endogenous neural stem cells in response to neurodegenerative process within the striatum. Neurodegenerative Diseases, 3, 12-18. doi:10.1159/000092087.
42. Miranda, K., Huynh, T., Tay, Y., Ang, Y. S., Tam, W. L., Thomson, A. M., et al. (2006). A pattern-based method for the identification of microRNA-target sites and their corresponding heteroduplexes. Cell, 126, 1203-1217. doi:10.1016/j.cell.2006.07.031.
43. Monteys, A. M., Spengler, R. M., Wan, J., Tecedor, L., Lennox, K. A., Xing, Y., et al. (2010). Structure and activity of putative intronic miRNA promoters. RNA, 16, 495-505. doi:10.1261/rna.1731910.
44. Nicolas, G., Devys, D., Goldenberg, A., Maltête, D., Hervé, C., Hannequin, D., et al. (2011). Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume. American Journal of Medical Genetics, 155A(4), 815-818. doi:10.1002/ajmg.a. 33911.
45. Nogales-Cadenas, R., Carmona-Saez, P., Vazquez, M., Vicente, C., Yang, X., Tirado, F., et al. (2009). GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Research, 37, Web Server issue, W317-372. doi:10.1093/nar/gkp416.
46. Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., & Davidson, B. L. (2008). The bifunctional microRNA miR-9/miR-9 regulates REST and CoREST and is downregulated in Huntington's disease. The Journal of Neuroscience, 28, 14341-14346. doi: 10.1523/JNEUROSCI.2390-08.2008.
47. Pelegrí, C., Duran-Vilaregut, J., del Valle, J., Crespo-Biel, N., Ferrer, I., Pallás, M., et al. (2008). Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid. International Journal of Developmental Neuroscience, 26, 665-671. doi:10.1016/j.ijdevneu.2008.07.016.
48. Rodriguez, A., Griffiths-Jonnes, S., Ashurst, J. L., & Bradley, A. (2004). Identification of mammalian microRNA host genes and transcription units. Genome Research, 14, 1902-1910. doi: 10.1101/gr.2722704.
49. Savas, J. N., Makusky, A., Ottosen, S., Baillat, D., Then, F., Krainc, D., et al. (2008). Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proceedings of the National academy of Sciences of the United States of America, 105, 10820-10825. doi:10.1073/pnas.0800658105.
50. Seredenina, T., & Luthi-Carter, R. (2011). What have we learned from gene expression profiles in Huntington's disease Neurobiology of Disease, July 12. (Epub ahead of print). doi: 10.1016/j.nbd.2011.07.001.
51. Simpson, J. M., Gil-Mohapel, J., Pouladi, M. A., Ghilan, M., Xie, Y., Hayden, M. R., et al. (2011). Altered adult hippocampalneurogenesis in the YAC128 transgenic mouse model of Huntington disease. Neurobiology of Disease, 41, 249-260. doi: 10.1016/j.nbd.2010.09.012.
52. Sinha, M., Ghose, J., & Bhattarcharyya, N. P. (2011). Micro RNA - 214,-150,-146a and -125b target Huntingtin gene. RNA Biology, 8 (6), 1005-1021. http://dx.doi.org/10.4161/rna.8.6.16035.
53. Sinha, M., Ghose, J., Das, E., & Bhattarcharyya, N. P. (2010). Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP. Biochemical and Biophysical Research Communications, 396, 742-747. doi:10.1016/j.bbrc.2010.05.007.
54. Snape, M., Lee, H. G., Casadesus, G., & Smith, M. A. (2009). Cell cycle aberrations in Alzheimer's disease: a novel therapeutic opportunity. Expert Review of Neurotherapeutics, 9, 1579-1580. doi:10.1586/ern.09.113.
55. Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., DemiReva, E., & Abeliovich, A. (2003). Parkin is a component of an SCF-like Ubiquitin ligase complex and protects postmitotic neurons from kainite cytotoxicity. Neuron, 37, 735-749. doi: 10.1016/S0896-6273(03)00084-9.
56. Sugars, K. L., & Rubinsztein, D. C. (2003). Transcriptional abnormalities in Huntington disease. Trends in Genetics, 19, 233-238. doi:10.1016/S0168-9525(03)00074-X.
57. Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009). Modulation of microRNA processing by p53. Nature, 460, 529-533. doi:10.1038/nature08199.
58. Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., et al. (2007). Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 6, 1586-1593. doi:10.4161/cc.6.13.4436.
59. The Huntington's Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell, 72, 971-983. doi:10.1016/0092-8674(93) 90585-E.
60. Thomas, M., Lieberman, J., & Lal, A. (2010). Desperately seeking microRNA targets. Nature Structural & Molecular Biology, 17, 1169-1174. doi:10.1038/nsmb.1921.
61. Thompson, A., Boekhoorn, K., Van Dam, A. M., & Lucassen, P. J. (2008). Changes in adult neurogenesis in neurodegenerative diseases: Cause or consequence Genes, Brain and Behavior, 1(Suppl 7), 28-42. doi:10.1111/j.1601- 183X.2007.00379.x.
62. Tong, Y., Ha, T. J., Liu, L., Nishimoto, A., Reiner, A., & Goldowitz, D. (2011). Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development. The Journal of Neuroscience, 31, 14794-14799. doi:10.1523/JNEUROSCI.2774-11.2011.
63. Trettel, F., Rigamonti, D., Hilditch-Maguire, P., Wheeler, V. C., Sharp, A. H., Persichetti, F., et al. (2000). Dominant phenotypes produced by the HD mutation in STHdh (Q111) striatal cells. Human Molecular Genetics, 9, 2799-2809. doi:10.1093/hmg/9.19.2799.
64. Vo, N., Klein, M. E., Varlamova, O., Keller, D. M., Yamamoto, T., Goodman, R. H., et al. (2005). A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proceedings of the National academy of Sciences of the United States of America, 102, 16426-16431. doi:10.1073/pnas.0508448102.
65. Wang, W., Bu, B., Xie, M., Zhang, M., Yu, Z., & Tao, D. (2009a). Neural cell cycle dysregulation and central nervous system diseases. Progress in Neurobiology, 89, 1-17. doi:10.1016/j.pneurobio.2009.01.007.
66. Wang, D., Lu, M., Miao, J., Li, T., Wang, E., & Cui, Q. (2009b). Cepred: predicting the co-expression patterns of the human intronic microRNAs with their host genes. PLoS ONE, 4, e4421. doi:10.1371/journal.pone.0004421.
67. Wang, J., Lu, M., Qiu, C., & Cui, Q. (2010). TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Research, 38, Database issue, D119-122. doi:10.1093/nar/gkp803.
68. Xi, Y., Shalgi, R., Fodstad, O., Pilpel, Y., & Ju, J. (2006). Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clinical Cancer Research, 12, 2014-2024. doi: 10.1158/1078-0432.CCR-05-1853.
69. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., & Li, T. (2009). miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Research, 37, Database issue, D105-110. doi:10.1093/nar/gkn851.
70. Yu, J., Wang, F., Yang, G. H., Wang, F. L., Ma, Y. N., Du, Z. W., et al. (2006). Human microRNA clusters: Genomic organization and expression profile in leukemia cell lines. Biochemical and Biophysical Research Communications, 349, 59-68. doi: 10.1016/j.bbrc.2006.07.207.
71. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., et al. (2003). Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nature Genetics, 35, 76-83. doi:10.1038/ng1219.